| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2012 | CA2382290C Gene regulating plant branching, vector containing the gene, microorganism transformed by the vector, and method for regulating plant branching by using the microorganism |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2370132C Auxin transport proteins |
| 01/24/2012 | CA2327350C Bacillus thuringiensis toxins and genes for controlling coleopteran pests |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/24/2012 | CA2274987C Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 01/24/2012 | CA2260754C Novel vegf-like factor |
| 01/24/2012 | CA2221318C High affinity oligonucleotide ligands to growth factors |
| 01/19/2012 | WO2012009693A1 Ancestral proteins |
| 01/19/2012 | WO2012009648A2 Novel nitrate reductase fusion proteins and uses thereof |
| 01/19/2012 | WO2012009471A1 Anti-angiogenic agent and method of using such agent |
| 01/19/2012 | WO2012009075A1 Materials and method for suppressing inflamatory and neuropathic pain |
| 01/19/2012 | WO2012007848A2 Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof |
| 01/19/2012 | WO2012007740A1 Neurodegenerative disorders |
| 01/19/2012 | WO2012007594A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 01/19/2012 | WO2012007593A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
| 01/19/2012 | WO2012007589A1 Live attenuated parvovirus |
| 01/19/2012 | WO2012007458A1 Gene therapy composition for use in diabetes treatment |
| 01/19/2012 | WO2012007380A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 01/19/2012 | WO2012007324A2 Stabilized factor viii variants |
| 01/19/2012 | WO2012007192A1 Asparaginase from basidiomycetes |
| 01/19/2012 | WO2012006962A1 Truncated human papillomavirus type 58 l1 protein |
| 01/19/2012 | WO2012006956A1 Insulin-lipid complex, preparation method therefor, and preparation thereof |
| 01/19/2012 | WO2012006866A1 BOTANICAL YELLOW DWARF DISEASE RESISTANT PROTEIN TiSTKI, CODING GENE AND APPLICATION THEREOF |
| 01/19/2012 | WO2012006732A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 01/19/2012 | WO2012006731A1 Deamidated barley proteins |
| 01/19/2012 | WO2012006730A1 Diagnostic method for colitis |
| 01/19/2012 | WO2012006727A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | WO2011143323A3 Programmable self-assembled nanostructures based on sidechain-modified pna for the multivalent display of ligands |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011131896A3 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/19/2012 | WO2011126897A3 Methods for enhancing by-products from fermentation processes |
| 01/19/2012 | WO2011126644A3 Plant peptide gamma-zein for delivery of biomolecules into plant cells |
| 01/19/2012 | WO2011112856A3 Novel protein peptide hydrogels |
| 01/19/2012 | WO2011109106A3 Immunogenic compositions against human progastrin peptides |
| 01/19/2012 | WO2011106681A3 SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS |
| 01/19/2012 | WO2011106676A3 Methods of human embryonic stem cell growth |
| 01/19/2012 | WO2011087491A9 Parstatin peptides and uses thereof |
| 01/19/2012 | WO2011086589A9 Process for the preparation of a biomass comprising plantaricin and uses thereof in medical field |
| 01/19/2012 | WO2010115133A8 Newcastle disease virus vectored avian vaccines |
| 01/19/2012 | US20120017330 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/19/2012 | US20120017317 Soybean variety a1024223 |
| 01/19/2012 | US20120017315 Soybean variety a1024213 |
| 01/19/2012 | US20120017314 Soybean variety a1024212 |
| 01/19/2012 | US20120017313 Soybean variety a1024210 |
| 01/19/2012 | US20120017312 Soybean variety a1024198 |
| 01/19/2012 | US20120017311 Soybean variety a1024197 |
| 01/19/2012 | US20120017310 Soybean variety a1024184 |
| 01/19/2012 | US20120017309 Soybean variety a1024181 |
| 01/19/2012 | US20120017305 Soybean variety a1024338 |
| 01/19/2012 | US20120017304 Soybean variety a1024337 |
| 01/19/2012 | US20120017303 Soybean variety a1024320 |
| 01/19/2012 | US20120017302 Soybean variety a1024319 |
| 01/19/2012 | US20120017301 Soybean variety a1022842 |
| 01/19/2012 | US20120017300 Soybean variety a1024318 |
| 01/19/2012 | US20120017299 Soybean variety a1024315 |
| 01/19/2012 | US20120017298 Soybean variety a1024305 |
| 01/19/2012 | US20120017297 Soybean variety a1024301 |
| 01/19/2012 | US20120017293 Soybean variety a1024238 |
| 01/19/2012 | US20120017288 Anticoagulant Fusion Protein Anchored to Cell Membrane |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016205 Biomarkers for diagnosing alzheimer's disease |
| 01/19/2012 | US20120016113 Buoyant protein harvesting device |
| 01/19/2012 | US20120016112 Processing of macronutrients |
| 01/19/2012 | US20120016111 Compositions for the treatment of cancer, and methods for testing and using the same |
| 01/19/2012 | US20120016110 Method of immobilizing and stretching a nucleic acid on a substrate |
| 01/19/2012 | US20120016107 Growth factor htter36 |
| 01/19/2012 | US20120016105 Purification of peptide conjugates by hydrophobic interaction chromatography |
| 01/19/2012 | US20120016104 Glycosylated il-7, preparation and uses |
| 01/19/2012 | US20120016102 Non-toxic biofilm inhibitor |
| 01/19/2012 | US20120016008 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN RIBOSOMAL PROTEIN L26 (RIBO26) |
| 01/19/2012 | US20120016003 Pot1 alternative splicing variants |
| 01/19/2012 | US20120015890 Use of Soluble Forms of CD83 and Nucleic Acids Encoding them for the Treatment or Prevention of Diseases |
| 01/19/2012 | US20120015888 T cell receptors and related materials and methods of use |
| 01/19/2012 | US20120015887 Synthetic peptide and uses thereof |
| 01/19/2012 | US20120015881 Kallikrein-inhibitor therapies |
| 01/19/2012 | US20120015877 Use of gdf traps to increase red blood cell levels |
| 01/19/2012 | US20120015876 Conjugates of glp-1 agonists and uses thereof |
| 01/19/2012 | US20120015872 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015871 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015870 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120015820 Methods and compositions for polypeptide engineering |
| 01/19/2012 | US20120015438 Mammallian cell culture process for protein production |
| 01/19/2012 | US20120015432 Isolated bitter taste receptor polypeptides |
| 01/19/2012 | US20120015425 Cellular Permissivity Factor for Viruses and Uses Thereof |
| 01/19/2012 | US20120015418 Genes and proteins for the biosynthesis of the lantibiotic 107891 |
| 01/19/2012 | US20120015401 Plasmodium falciparum antigens and methods of use |
| 01/19/2012 | US20120015387 Marker peptides for determining the occurrence of an inflammatory state in a subject |
| 01/19/2012 | US20120015379 Diagnosis of bacillus anthracis infection based on detection of bacterial secreted biomarkers |
| 01/19/2012 | US20120015345 Identification of Oligonucleotides for the Capture, Detection and Quantitation of West Nile Virus |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120014998 Modified chaperonin 10 |
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014973 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
| 01/19/2012 | US20120014965 Compositions and methods of treating tumors |
| 01/19/2012 | US20120014964 Alpha synuclein toxicity |
| 01/19/2012 | US20120014961 Antibodies that inhibit tslp activity |